RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Gross margin (%)

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndGross margin (%) YoY (%)
Dec 31, 202451.1-6.26%
Dec 31, 202354.5+9.25%
Dec 31, 202249.9+9.31%
Dec 31, 202145.6+11.36%
Dec 31, 202041+0.12%
Dec 31, 201940.9+12.72%
Dec 31, 201836.3-3.96%
Dec 31, 201737.8-7.42%
Dec 31, 201640.8+32.78%
Dec 31, 201530.8+26.27%
Dec 31, 201424.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)